oleoylehtanolamide
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Apr 8, 2021 (NCT05017428)
Timeline
No events for the selected filters.
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06840080 | Phase 4 | Mar 4, 2025 | Gencor, RDC Clinical Pty Ltd |
| NCT05017428 | N/A | Apr 8, 2021 | University of California, Davis |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Gencor | For profit | 1 | 0 | 1 | 2025 |
| RDC Clinical Pty Ltd | For profit | 1 | 1 | 1 | 2025 |
| University of California, Davis | Academic/Hospital | 1 | 1 | 1 | 2021 |
3 organizations
Page 1 / 1